Home Healthcare Medical Devices Brachytherapy Treatment Planning Systems Market

Brachytherapy Treatment Planning Systems Market Size, Share & Trends Analysis Report By Component (Auto-Contouring Software, Multi-Modality Software, PET/CT Deformable Software, DICOM-RT Software), By Technique (3D Image Reconstruction, In-Room Imaging, Image Registration using Graphics Processing Unit) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: November 19, 2026 | Author: Straits Research Team | Report Code: SR9326DR

Brachytherapy Treatment Planning Systems Market Size & Share Analysis

The global brachytherapy treatment planning systems market size was valued at USD 904.04 million in 2025 and is projected to grow from USD 986.67 million in 2026 to USD 986.67 million by 2034, registering a CAGR of 9.14% during the forecast period (2026-2034). North America dominated the brachytherapy treatment planning systems market with a share of 38.55% in 2025.

The National Cancer Institute (NCI) defines brachytherapy as a type of internal radiation therapy in which radioactive implants, such as seeds, ribbons, wires, needles, or capsules, are placed directly into or near a tumor to deliver localized radiation. These systems support HDR brachytherapy, LDR brachytherapy, image guided brachytherapy, and brachytherapy dosimetry, enabling accurate dose calculation and radiation treatment planning across hospitals and cancer treatment centers.

The brachytherapy treatment planning systems market demand is driven by the adoption of precision oncology, wider use of image-guided procedures, and the need for accurate dose calculation. Cancer centers are adopting brachytherapy planning software to improve treatment precision and workflow efficiency, contributing to brachytherapy treatment planning systems market growth.

Brachytherapy Treatment Planning Systems Market Key Takeaways

Global Market Size & Growth

2025 Market Size
USD 904.04 Billion
2026 Market Size
USD 986.67 Billion
2034 Projected Market Size
USD 1986.29 Billion
Forecast Period
2026-2034
Base Year
2025
Market CAGR (2026-2034)
9.14%

Regional Insights

Largest Regional Market (2025)
North America
North America Market Share (2025)
38.55%
Fastest-growing Region
Asia Pacific
Asia Pacific CAGR (2026-2034)
11.29%

Segment Insights

By Component
Leading Segment
Auto-Contouring Software
Market Share in 2025 32.5%
By Technique
Fastest-growing Segment
Image Registration using Graphics Processing Unit
CAGR 11.28% (2026-2034)
Brachytherapy Treatment Planning Systems Market Size , Share and Growth Forecast 2026-2034

Download a Free SampleTo learn more about this report.

Brachytherapy Treatment Planning Systems Market Dynamics

01

MRI-Guided Brachytherapy Strengthens Demand for Advanced Planning Systems

The use of MRI-guided brachytherapy increases the need for precise tumor visualization and treatment planning. MRI images help clinicians assess tumor boundaries and nearby organs before determining radiation delivery. This supports demand for advanced brachytherapy planning software, dose calculation, and brachytherapy dosimetry solutions, contributing to market growth.

02

Expansion of HDR Brachytherapy Boosts Planning Software Demand

Adoption of HDR brachytherapy is increasing the need for specialized treatment planning systems that support accurate radiation delivery. These systems help clinicians determine dwell positions, radiation source strength, and dose distribution for individual patients. This supports demand for advanced brachytherapy treatment planning systems and radiation treatment planning solutions.

03

Impact Analysis of Key Drivers in Brachytherapy Treatment Planning Systems Market

DriversMarket Impact

MRI-Guided Brachytherapy Strengthens Demand for Advanced Planning Systems

MRI guidance improves dose accuracy during brachytherapy procedures.

Expansion of HDR Brachytherapy Boosts Planning Software Demand

HDR procedures increase demand for specialized brachytherapy planning software.

Adaptive Treatment Planning Improves Brachytherapy Dosimetry

Adaptive planning supports more precise brachytherapy dosimetry.

Complex Gynecological Cancer Treatments Increase Demand for Image-Guided Planning

Image guidance improves treatment accuracy in complex procedures.

3D Imaging Integration Supports Personalized Radiation Treatment Planning

3D imaging enables more accurate dose calculation and treatment planning.

01

Limited Availability of Trained Medical Physicists Delays System Utilization

Brachytherapy treatment planning systems require skilled medical physicists to perform brachytherapy dosimetry, verify treatment plans, and ensure accurate radiation delivery. Shortages of trained professionals increase planning time and limit the effective use of brachytherapy planning software. These workforce constraints restrict the adoption of advanced brachytherapy treatment planning system products across cancer centers.

02

Interoperability Issues with Treatment Delivery Equipment Complicate Workflow Integration

Compatibility issues between planning platforms and treatment delivery equipment complicate data transfer and clinical workflows. Differences in software formats affect the integration of brachytherapy treatment planning systems technology with HDR and LDR treatment equipment. These challenges increase implementation costs and restrict the adoption of integrated radiation treatment planning solutions.

03

Impact Analysis of Key Restraints in Brachytherapy Treatment Planning Systems Market

RestraintsMarket Impact

High Software Licensing Costs Restrict Adoption in Smaller Cancer Centers

Increases financial barriers to adopting advanced brachytherapy planning software.

Limited Availability of Trained Medical Physicists Delays System Utilization

Restricts the effective use of brachytherapy dosimetry solutions.

Interoperability Issues with Treatment Delivery Equipment Complicate Workflow Integration

Increases integration costs for brachytherapy treatment planning systems.

Complex Quality Assurance Requirements Increase Planning Workload

Raises operational costs and extends treatment preparation time.

Dependence on Specialized Applicators Limits Treatment Planning Flexibility

Restricts the use of brachytherapy treatment planning systems products across different clinical applications.

01

AI-Based Treatment Plan Automation Opens New Revenue Avenues for Software Developers

Brachytherapy treatment planning systems manufacturers integrate AI tools into brachytherapy planning software to automate contouring, optimize dose distribution, and streamline treatment plan preparation. These solutions help clinicians reduce manual planning tasks and improve workflow efficiency. Revenue opportunities include AI-enabled software modules, licensing agreements, and customized brachytherapy treatment planning system solutions for cancer centers.

02

Brachytherapy Planning Solutions for Veterinary Oncology Offer New Market Opportunities

Medical technology companies develop specialized brachytherapy treatment planning systems for veterinary hospitals treating tumors in companion animals. Adapted brachytherapy dosimetry tools and treatment planning applications can support radiation delivery for different animal anatomies. Revenue opportunities include veterinary-specific brachytherapy planning software, equipment sales, and partnerships with veterinary oncology centers.

Brachytherapy Treatment Planning Systems Market

By Component

Auto contouring software accounted for a share of 32.5% in 2025, supported by its role in improving target delineation, streamlining radiation treatment planning, and enhancing workflow efficiency in brachytherapy procedures.

PET/CT deformable software is projected to register a CAGR of 11.42% between 2026 and 2034, driven by the adoption of image guided brachytherapy and the need for accurate image registration and anatomical alignment during brachytherapy dosimetry.

Brachytherapy Treatment Planning Systems Market Size By Segments

Request Customizationto receive a tailored report.

By Technique

In 2025, 3D image reconstruction had a share of 43.5%, reflecting its importance in anatomical visualization, precise dose calculation, and accurate radiation treatment planning for targeted brachytherapy delivery.

A CAGR of 11.28% is anticipated for image registration using graphics processing units (GPUs) between 2026 and 2034, driven by demand for faster image processing and accurate anatomical alignment in image guided brachytherapy and advanced brachytherapy dosimetry workflows.

Brachytherapy Treatment Planning Systems Market Share By Segments

Speak to an Analystto discuss market opportunities.

Brachytherapy Treatment Planning Systems Market Regional Analysis

North America Brachytherapy Treatment Planning Systems Market

North America dominated the brachytherapy treatment planning systems market, with a share of 38.55% in 2025.

U.S. Brachytherapy Treatment Planning Systems Market

University of California San Diego and several other US cancer centers published a clinical evaluation of AI-based automated planning for cervical brachytherapy. The automated plans achieved quality scores comparable to manual clinical plans and were generated in a median of 1.4 minutes, highlighting the potential of AI-enabled brachytherapy planning software to improve planning efficiency and support precise brachytherapy dosimetry.

Canada Brachytherapy Treatment Planning Systems Market

McGill University and the Lady Davis Institute at Jewish General Hospital in Montréal updated validation of RapidBrachyMCTPS 3.0, a Monte Carlo-based brachytherapy treatment planning system. This advancement strengthens the technical capabilities of brachytherapy planning software, supporting more accurate brachytherapy dosimetry and treatment-plan evaluation.

North America Brachytherapy Treatment Planning Systems Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Brachytherapy Treatment Planning Systems Market

The Asia Pacific brachytherapy treatment planning systems market is expected to witness a CAGR of 11.29% during the forecast period.

Japan Brachytherapy Treatment Planning Systems Market

Nagasaki University Hospital published a procurement notice for an HDR brachytherapy system, following an earlier March 2026 request for materials that specified a dedicated treatment planning system and integration with existing radiology information and image archiving systems. This procurement supports demand for integrated image guided brachytherapy, treatment planning software, and dose calculation capabilities.

China Brachytherapy Treatment Planning Systems Market

China is advancing research into automated quality assurance for brachytherapy treatment planning systems. Shanxi Province Cancer Hospital and other Chinese medical institutions published work on the development and clinical evaluation of an automatic verification system for Oncentra brachytherapy treatment planning. This research highlights efforts to improve treatment-plan verification and reduce planning errors, supporting the development of more reliable brachytherapy dosimetry and planning solutions.

India Brachytherapy Treatment Planning Systems Market

India's public healthcare infrastructure is creating procurement demand for integrated brachytherapy equipment and planning technology. Tata Memorial Centre issued a tender for an HDR cobalt-60 brachytherapy unit with a dedicated treatment planning system and accessories for its hospital in Jatni, Odisha. The procurement covers equipment supply and installation, creating a direct requirement for brachytherapy planning software, treatment planning equipment, and associated dose calculation capabilities.

Europe Brachytherapy Treatment Planning Systems Market

Europe's brachytherapy treatment planning systems market is estimated to grow at a CAGR of 8.35% during the forecast period.

Germany Brachytherapy Treatment Planning Systems Market

Germany has an established base of medical software developers with products for brachytherapy applications. MedCom's June 2026 radiation oncology portfolio information lists Oncentra Prostate, a real-time planning system for temporary HDR/PDR and permanent LDR implants. This provides evidence of an active specialized software portfolio in Germany, although it is a product portfolio update rather than a newly launched system or confirmed hospital procurement.

U.K. Brachytherapy Treatment Planning Systems Market

UK is supported by NHS investment in the maintenance and continuity of specialized treatment-planning infrastructure. Southampton University Hospitals NHS Trust advertised a senior brachytherapy physics position that specifically involved managing its HDR treatment service, which uses Elekta's Oncentra Brachy planning system, and its LDR prostate service, which uses Varian's VariSeed software. The continued use and management of dedicated HDR and LDR planning platforms reinforces the need for specialized brachytherapy planning software, treatment optimization, and accurate brachytherapy dosimetry.

Latin America Brachytherapy Treatment Planning Systems Market

Latin America's brachytherapy treatment planning systems market is projected to expand at a CAGR of 9.48% during the forecast period.

Brazil Brachytherapy Treatment Planning Systems Market

Public healthcare infrastructure in Brazil is receiving renewed attention through government procurement and equipment planning for cancer treatment. The Institute of Strategic Health Management of the Federal District opened a tender for a remote-controlled brachytherapy system for Hospital de Base do Distrito Federal. This procurement supports the expansion of brachytherapy treatment capacity.

Mexico Brachytherapy Treatment Planning Systems Market

Mexico's brachytherapy treatment planning systems market is supported by public healthcare procurement of integrated radiation planning and treatment services. The Mexican Institute of Social Security (IMSS) issued a contract in Coahuila that included radiation therapy simulation, treatment planning, dosimetry, and brachytherapy sessions, with contracts awarded to two healthcare service providers in March 2026.

Middle East & Africa Brachytherapy Treatment Planning Systems Market

The Middle East & Africa brachytherapy treatment planning systems market is anticipated to register a growth rate of 9.82% during the forecast period.

UAE Brachytherapy Treatment Planning Systems Market

UAE University and the Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, outlined a two-year project to develop a real-time adaptive planning system for cervical cancer using AI-based image segmentation and multimodality image registration. The project supports research into more individualized image guided brachytherapy and automated treatment-plan optimization.

South Africa Brachytherapy Treatment Planning Systems Market

The Eastern Cape Government opened the R416 million Laura Mphahlwa Oncology Unit at Nelson Mandela Academic Hospital in Mthatha, introducing radiotherapy and brachytherapy services alongside two linear accelerator machines and dedicated oncology facilities. The expansion of local brachytherapy services supports the need for specialized brachytherapy planning software, accurate dose calculation, and integrated radiation treatment planning capabilities.

Competitive Landscape

The brachytherapy treatment planning systems market competitive landscape includes radiation therapy equipment manufacturers, medical imaging companies, and oncology software developers. Key players such as Elekta, Varian Medical, RaySearch Laboratories, Siemens, and MIM Software are estimated to account for 40–50% of the global brachytherapy treatment planning systems market share.

Established players compete through treatment accuracy, advanced imaging integration, software capabilities, and clinical reliability. Emerging players focus on AI-based treatment planning, automated dose optimization, and advanced imaging technologies to improve treatment precision.

List of Key and Emerging Players in Brachytherapy Treatment Planning Systems Market

Elekta AB (Sweden)
Varian Medical Systems, Inc. (US)
RaySearch Laboratories AB (Sweden)
Siemens Healthineers AG (Germany)
MIM Software Inc. (US)
Prowess, Inc. (US)
BEBIG Medical GmbH (Germany)
Theragenics Corporation (US)
Perspective Therapeutics, Inc. (US)
C4 Imaging LLC (US)
Brainlab AG (Germany)

Key Industry Developments

June 2026
GE HealthCare received FDA clearance for MIM Contour ProtégéAI+ 2.0, expanding AI-based contouring capabilities for radiation oncology and integration with radiation treatment planning workflows.
May 2026
Philips received FDA 510(k) clearance for its Multimodality Simulation Workspace, supporting 3D/4D image visualization and treatment preparation for brachytherapy and other radiation procedures.

Report Scope

Segmentation

By Component 4
  • Auto-Contouring Software
  • Multi-Modality Software
  • PET/CT Deformable Software
  • DICOM-RT Software
By Technique 3
  • 3D Image Reconstruction
  • In-Room Imaging
  • Image Registration using Graphics Processing Unit

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Elekta AB (Sweden) · Varian Medical Systems, Inc. (US) · RaySearch Laboratories AB (Sweden) · Siemens Healthineers AG (Germany) · MIM Software Inc. (US)
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Reportto Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The brachytherapy treatment planning systems market size is valued at USD 986.67 Billion in 2026 and is projected to reach USD 1,986.29 Billion by 2034, at a CAGR of 9.14% during the forecast period 2026-2034.
North America dominated the market with a share of 38.55% in 2025.
The leading brands in this market are Elekta AB, Varian Medical Systems, Inc., RaySearch Laboratories AB, Siemens Healthineers AG, MIM Software Inc., Prowess, Inc., BEBIG Medical GmbH, Theragenics Corporation, Perspective Therapeutics, Inc., C4 Imaging LLC, and Brainlab AG.
The brachytherapy treatment planning systems market is projected to grow at a CAGR of 9.14% during the forecast period of 2026-2034.
About the Author
Straits Research Team
Straits Research Team
Research Experts

The Straits Research Team is a group of experienced researchers, analysts, and industry professionals dedicated to delivering reliable, insightful, and well-structured market intelligence. With expertise across multiple sectors and domains, the team combines extensive research, data analysis, and industry knowledge to provide a clear understanding of evolving markets and business environments.

The team focuses on identifying key market trends, emerging opportunities, technological developments, competitive landscapes, and changing industry dynamics. Through a thoughtful and research-driven approach, it aims to provide valuable insights that help businesses, investors, and decision-makers better understand their industries and make informed strategic decisions.

Report Details
−
Trusted by Industry Leaders
LG ElectronicsAMCAD EngineeringKOBE STEEL LTD.Hindustan National Glass & Industries LimitedVoith GroupInternational PaperHansol PaperWhirlpool CorporationSonySamsung ElectronicsQualcommGoogleFiservVeto-PharmaNippon Becton DickinsonMerckArgon Medical DevicesAbbottAjinomotoDenonDoosanMeiji Seika Kaisha LtdLG ChemicalsLCY chemical groupBayerAirraneBASFToyota IndustriesNissan MotorsNeenahMitsubishiHyundai Motor CompanyHondaCRP Industries IncpewagLGEPanasonicLubrizol CorporationLeonardoJohnson & JohnsonHB FullerMITSUBISHI CHEMICALHyundai MobisAmazon
Request SampleOrder Report Now